GlobeNewswire 11:05 PM I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...
GlobeNewswire 11:05 PM Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...
GlobeNewswire 11:05 PM Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
GlobeNewswire 11:05 PM FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire 11:05 PM NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...
GlobeNewswire 11:05 PM Elcora Announces Share Consolidation
GlobeNewswire 11:05 PM Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study i...
GlobeNewswire 11:04 PM Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...
GlobeNewswire 11:03 PM Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...
GlobeNewswire 11:01 PM Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...
GlobeNewswire 11:01 PM Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire 11:01 PM HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical...
GlobeNewswire 11:00 PM Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Co...
TeleTrader 11:00 PM Iran-backed militia claims drone attack on Eilat
GlobeNewswire 11:00 PM Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term E...
GlobeNewswire 11:00 PM Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire 11:00 PM Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
GlobeNewswire 11:00 PM MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBIN...
GlobeNewswire 11:00 PM Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m...
GlobeNewswire 11:00 PM Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire 11:00 PM Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire 11:00 PM NVIDIA Announces Upcoming Event for Financial Community
GlobeNewswire 11:00 PM Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...
GlobeNewswire 11:00 PM Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology A...
GlobeNewswire 11:00 PM Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monothera...